Financials data is unavailable for this security.
View more
Year on year CorMedix Inc 's revenues fell -100.00% from 65.41k to 0.00. has fallen 56.02% from a loss of 29.70m to a larger loss of 46.34m.
| Gross margin | -64.79% |
|---|---|
| Net profit margin | -6,589.09% |
| Operating margin | -7,212.46% |
| Return on assets | -92.57% |
|---|---|
| Return on equity | -111.55% |
| Return on investment | -110.35% |
More ▼
Cash flow in USDView more
In 2023, CorMedix Inc did not generate a significant amount of cash. Cash Flow from Financing totalled 55.92m or -- of revenues. In addition the company used 38.41m for operations while cash used for investing totalled 17.06m.
| Cash flow per share | -0.9249 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.8355 |
|---|---|
| Tangible book value per share | 0.8003 |
More ▼
Balance sheet in USDView more
| Current ratio | 4.79 |
|---|---|
| Quick ratio | 4.43 |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
